Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M511419200 on January 23, 2006

J. Biol. Chem., Vol. 281, Issue 13, 8773-8779, March 31, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/13/8773    most recent
M511419200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toso, R.
Right arrow Articles by Camire, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toso, R.
Right arrow Articles by Camire, R. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Role of Hirudin-like Factor Va Heavy Chain Sequences in Prothrombinase Function*

Raffaella Toso{ddagger} and Rodney M. Camire{ddagger}§1

From the {ddagger}Department of Pediatrics, Division of Hematology, The Children's Hospital of Philadelphia and §University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104

Proexosite I on prothrombin has been implicated in providing a recognition site for factor Va within prothrombinase. To examine whether hirudin-like sequences (659–698) on the cofactor contribute to this interaction, we expressed and purified two-chain FVa derivatives that were intracellularly truncated at the C terminus of the heavy chain: FVa709 (des710–1545), FVa699 (des700–1545), FVa692 (des693–1545), FVa678 (des679–1545), and FVa658 (des659–1545). We found that FVa709, FVa699, FVa692, and FVa678 exhibited specific clotting activities that were comparable with plasma-derived and recombinant FVa. Additionally, kinetic studies using prothrombin revealed that the Km and kcat values for these derivatives were unaltered. Fluorescent measurements and chromatography studies indicated that FVa709, FVa699, FVa692, and FVa678 bound to FXa membranes and thrombin-agarose in a manner that was comparable with the wild-type cofactors. In contrast, FVa658 had an ~1% clotting activity and reduced affinity for FXa membranes (~20-fold) and did not bind to thrombin-agarose. Surprisingly, however, FVa658 exhibited essentially normal kinetic parameters for prothrombin when the variant was fully saturated with FXa membranes. Overall our results are consistent with the interpretation that any possible binding interactions between prothrombin and the C-terminal region of the FVa heavy chain do not contribute in a detectable way to the enhanced function of prothrombinase.


Received for publication, October 20, 2005 , and in revised form, December 9, 2005.

* This work was supported by National Institutes of Health Grants P01 HL-74124-01, Project 2 (to R. M. C.), and National Research Service Award T32 HL-07439-26 (to R. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Div. of Hematology, 302E Abramson Research Center, The Children's Hospital of Philadelphia, 3615 Civic Center Blvd., Philadelphia, PA 19104. Tel.: 215-590-9968; Fax: 215-590-3660; E-mail: rcamire{at}mail.med.upenn.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Toso, H. Zhu, and R. M. Camire
The Conformational Switch from the Factor X Zymogen to Protease State Mediates Exosite Expression and Prothrombinase Assembly
J. Biol. Chem., July 4, 2008; 283(27): 18627 - 18635.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Y. Kim and M. E. Nesheim
Further Evidence for Two Functional Forms of Prothrombinase Each Specific for Either of the Two Prothrombin Activation Cleavages
J. Biol. Chem., November 9, 2007; 282(45): 32568 - 32581.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Gale, S. Yegneswaran, X. Xu, J.-L. Pellequer, and J. H. Griffin
Characterization of a Factor Xa Binding Site on Factor Va near the Arg-506 Activated Protein C Cleavage Site
J. Biol. Chem., July 27, 2007; 282(30): 21848 - 21855.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhu, R. Toso, and R. M. Camire
Inhibitory Sequences within the B-domain Stabilize Circulating Factor V in an Inactive State
J. Biol. Chem., May 18, 2007; 282(20): 15033 - 15039.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement